Harbeck, N.; Gluz, O.; Christgen, M.; Braun, M.; Kuemmel, S.; Schumacher, C.; Potenberg, J.; Kraemer, S.; Kleine-Tebbe, A.; Augustin, D.; Aktas, B.; Forstbauer, H.; Tio, J.; Liedtke, C.; Kates, R. E.; Wuerstlein, R.; Haas, S. L. de; Kiermaier, A.; Kreipe, H. H. and Nitz, U.
(2016):
Final analysis of WSG-ADAPT HER2+/HR+ phase II trial: Efficacy, safety, and predictive markers for 12-weeks of neoadjuvant TDM1 with or without endocrine therapy versus trastuzumab plus endocrine therapy in HER2-positive hormone-receptor positive early breast cancer.
In: Cancer Research, Vol. 76
| Item Type: | Journal article |
|---|---|
| Faculties: | Medicine |
| Subjects: | 600 Technology > 610 Medicine and health |
| ISSN: | 0008-5472 |
| Language: | English |
| Item ID: | 44180 |
| Date Deposited: | 27. Apr 2018, 08:05 |
| Last Modified: | 23. Dec 2020, 13:16 |
Actions (login required)
- View Item
